US4755180A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Dosage form comprising solubility regulating member
Assignee: Alza Corp
•
Filing: 1986-06-16
•
Granted: 1988-07-05
•
Expires: 2006-06-16
Abstract
Abstract An osmotic dosage form is disclosed comprising a polymeric olefin, vinyl, condensation, addition or silicon film that surrounds a member selected from the group consisting of a buffer and osmogent which member is released by the film as a means for governing the solubility of a beneficial agent in the dosage form.
Inventors
- 👤 Atul D. Ayer
- 👤 Patrick S. L. Wong
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 12:25
CPC Classifications
A; A61; A61M; A61M31/00; A61M31/002; A61K; A61K9/00; A61K9/0002; A61K9/0004
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
213 words
A dosage form for delivering a beneficial drug formulation to a biological environment of use, wherein the dosage form comprises: (a) a wall comprising a composition that maintains its physical and chemical integrity during the life of the dosage form, is substantially impermeable to the passage of a beneficial agent formulation, and at least in part is permeable to the passage of exterior fluid present in the biological environment, which wall surrounds and forms; (b) a compartment; (c) a dosage amount of a beneficial drug formulation in the compartment; (d) means for aiding in controlling the solubility of the drug formulation in the presence of external fluid imbibed into the compartment, said means comprising a release rate controlling film selected from the group consisting of olefin and vinyl polymers, condensation polymers, addition polymers and organo-silicon polymers, which film surrounds a buffer that is released at a controlled rate by the film into the compartment for governing the solubility of the drug formulation and correspondingly aiding in osmotically and hydrodynamically delivering the drug formulation from the dosage form; and, (e) exit means in the wall of the dosage form that connects the internal compartment with the exterior environment of use for delivering the drug formulation in a therapeutically effective amount from the dosage form.
Claim 2
Dependent Claim
213 words
A dosage form for delivering a beneficial drug formulation to a biological environment of use, wherein the dosage form comprises: (a) a wall comprising a composition that maintains its physical and chemical integrity during the life of the dosage form, is substantially impermeable to the passage of a beneficial agent formulation, and at least in part is permeable to the passage of exterior fluid present in the biological environment, which wall surrounds and forms; (b) a compartment; (c) a dosage amount of a beneficial drug formulation in the compartment; (d) means for aiding in controlling the solubility of the drug formulation in the presence of external fluid imbibed into the compartment, said means comprising a release rate controlling film selected from the group consisting of olefin and vinyl polymers, condensation polymers, addition polymers and organo-silicon polymers, which film surrounds a buffer that is released at a controlled rate by the film into the compartment for governing the solubility of the drug formulation and correspondingly aiding in osmotically and hydrodynamically delivering the drug formulation from the dosage form; and, (e) exit means in the wall of the dosage form that connects the internal compartment with the exterior environment of use for delivering the drug formulation in a therapeutically effective amount from the dosage form.
Claim 3
Dependent Claim
204 words
A dosage form for delivering a beneficial drug formulation to an environment of use, the dosage form comprising: (a) a wall comprising a composition that maintains its physical and chemical integrity during the life of the dosage form, is substantially impermeable to the passage of a drug formulation, and at least in part is permeable to the passage of exterior fluid, which wall surrounds and defines; (b) a compartment; (c) a dosage amount of a beneficial drug formulation in the compartment; (d) means for governing the solubility of the drug formulation in the compartment in the presence of fluid imbibed into the compartment, said means comprising a release rate controlling film selected from the goup consisting of olefin and vinyl polymers, condensation polymers, addition polymers and organo-silicon polymers, which film surrounds an osmagent that is released at a controlled rate into the compartment by the film for governing the solubility of the drug formulation in the compartment and for correspondingly aiding in osmotically and hydrodynamically delivering the drug formulation from the doage form; and, (e) exit means in the wall of the dosage form that connects the compartment with the exterior of the dosage form for delivering the drug formulation from the dosage form.
Claim 4
Dependent Claim
204 words
A dosage form for delivering a beneficial drug formulation to an environment of use, the dosage form comprising: (a) a wall comprising a composition that maintains its physical and chemical integrity during the life of the dosage form, is substantially impermeable to the passage of a drug formulation, and at least in part is permeable to the passage of exterior fluid, which wall surrounds and defines; (b) a compartment; (c) a dosage amount of a beneficial drug formulation in the compartment; (d) means for governing the solubility of the drug formulation in the compartment in the presence of fluid imbibed into the compartment, said means comprising a release rate controlling film selected from the goup consisting of olefin and vinyl polymers, condensation polymers, addition polymers and organo-silicon polymers, which film surrounds an osmagent that is released at a controlled rate into the compartment by the film for governing the solubility of the drug formulation in the compartment and for correspondingly aiding in osmotically and hydrodynamically delivering the drug formulation from the doage form; and, (e) exit means in the wall of the dosage form that connects the compartment with the exterior of the dosage form for delivering the drug formulation from the dosage form.
Claim 5
Dependent Claim
41 words
The dosage form for delivering a beneficial drug formulation according to claim 2, wherein the exit means is formed in the wall when the dosage form is in the environment of use by fluid leaching a leachable compound from the wall.
Claim 6
Dependent Claim
34 words
The dosage form for delivering a beneficial drug formulation according to claim 2, wherein the exit means comprises at least one pore of controlled porosity for delivering the drug formulation from the dosage form.
Claim 7
Dependent Claim
22 words
The dosage form for delivering a beneficial drug formulation according to claim 2, wherein the exit means comprises a plurality of micropores.
References Cited (Backward Citations)
US1815902A
Cited
US3845770A
Cited
US3916899A
Cited
US4008719A
Cited
US4200098A
Cited
US4235236A
Cited
US4320759A
Cited
US4379454A
Cited
WO1983003061A1
Cited
FR2524311A1
Cited
US4553973A
Cited
US4610686A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-07-05 | 1992-01-04 | 1992-07-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-07-05 | 1996-01-04 | 1996-07-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-07-05 | 2000-01-04 | 2000-07-05 | $7700.00 | Window Closed / Lapsed |